Update on the role of C1GALT1 in cancer (Review)

被引:5
|
作者
Xia, Tong [1 ]
Xiang, Ting [1 ]
Xie, Hailong [1 ]
机构
[1] Univ South China, Hunan Prov Key Lab Tumor Cellular & Mol Pathol, Inst Canc Res, Sch Med, 28 Changsheng West Rd, Hengyang 421001, Hunan, Peoples R China
关键词
glycan; glycosylation; glycosyltransferase; core 1 beta 1,3-galactosyltransferase; T-synthase; HEPATOCELLULAR-CARCINOMA CELLS; PREDICTS POOR-PROGNOSIS; BREAST-CANCER; O-GLYCOSYLATION; EPH RECEPTORS; IN-VITRO; PROTEIN GLYCOSYLATION; MOLECULAR CHAPERONE; C-MET; SPONTANEOUS COLITIS;
D O I
10.3892/ol.2022.13217
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer remains one of the most difficult diseases to treat. In the quest for early diagnoses to improve patient survival and prognosis, targeted therapies have become a hot research topic in recent years. Glycosylation is the most common posttranslational modification in mammalian cells. Core 1 beta 1,3-galactosyltransferase (C1GALT1) is a key glycosyltransferase in the glycosylation process and is the key enzyme in the formation of the core 1 structure on which most complex and branched O-glycans are formed. A recent study reported that C1GALT1 was aberrantly expressed in tumors. In cancer cells, C1GALT1 is regulated by different factors. In the present review, the expression of C1GALT1 in different tumors and its possible molecular mechanisms of action are described and the role of C1GALT1 in cancer development is discussed.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] C1GALT1 expression predicts poor survival in osteosarcoma and is crucial for ABCC1 transporter-mediated doxorubicin resistance
    Liu, Chun-Wei
    Huang, Jing-Hui
    Chang, Hsiu-Hao
    Chen, Chia-Hua
    Tsai, Yi-Huan
    Chen, Wei-Li
    Lin, Jung-An
    Chang, Hsiu-Ling
    Chen, Cheng-Chang
    Lin, Mei-Chun
    Huang, Min-Chuan
    Lin, Neng-Yu
    JOURNAL OF PATHOLOGY, 2025, 265 (03) : 289 - 301
  • [22] C1GALT1 expression is associated with galactosylation of IgA1 in peripheral B lymphocyte in immunoglobulin a nephropathy
    Xing, Yue
    Li, Lina
    Zhang, Yaru
    Wang, Fanghao
    He, Dandan
    Liu, Youxia
    Jia, Junya
    Yan, Tiekun
    Lin, Shan
    BMC NEPHROLOGY, 2020, 21 (01)
  • [23] Clinic implication of MUC1 O-glycosylation and C1GALT1 in esophagus squamous cell carcinoma
    Yuming Wang
    Xiaodong Liao
    Qing Ye
    Lei Huang
    Science China(Life Sciences), 2018, (11) : 1389 - 1395
  • [24] Clinic implication of MUC1 O-glycosylation and C1GALT1 in esophagus squamous cell carcinoma
    Wang, Yuming
    Liao, Xiaodong
    Ye, Qing
    Huang, Lei
    SCIENCE CHINA-LIFE SCIENCES, 2018, 61 (11) : 1389 - 1395
  • [25] C1GALT1 high expression enhances the progression of glioblastoma through the EGFR-AKT/ERK cascade
    Su, Yanting
    Ao, Xin
    Long, Yunfeng
    Zhang, Zhengrong
    Zhang, Mingzhu
    Zhang, Zhenwang
    Wei, Mingjie
    Shan, Shigang
    Lu, Surui
    Yu, You
    Xu, Bo
    CELLULAR SIGNALLING, 2025, 125
  • [26] C1GALT1 expression predicts a favorable prognosis and suppresses malignant phenotypes via TrkA signaling in neuroblastoma
    Lin, Neng-Yu
    Chen, Syue-Ting
    Chang, Hsiu-Ling
    Lu, Meng-Yao
    Yang, Yung-Li
    Chou, Shu-Wei
    Lin, Dong-Tsamn
    Lin, Kai-Hsin
    Jou, Shiann-Tarng
    Hsu, Wen-Ming
    Huang, Min-Chuan
    Chang, Hsiu-Hao
    ONCOGENESIS, 2022, 11 (01)
  • [27] Clinic implication of MUC1 O-glycosylation and C1GALT1 in esophagus squamous cell carcinoma
    Yuming Wang
    Xiaodong Liao
    Qing Ye
    Lei Huang
    Science China Life Sciences, 2018, 61 : 1389 - 1395
  • [28] Dysregulation and prometastatic function of glycosyltransferase C1GALT1 modulated by cHP1BP3/ miR-1-3p axis in bladder cancer
    Tan, Zengqi
    Jiang, Yazhuo
    Liang, Liang
    Wu, Jinpeng
    Cao, Lin
    Zhou, Xiaoman
    Song, Zhihui
    Ye, Zhenyu
    Zhao, Ziyan
    Feng, Hui
    Dong, Zewen
    Lin, Shuai
    Zhou, Zhangjian
    Wang, Yili
    Li, Xiang
    Guan, Feng
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [29] Inhibition of the galactosyltransferase C1GALT1 reduces osteosarcoma cell proliferation by interfering with ERK signaling and cell cycle progression
    Watanabe, Kentaro
    Tasaka, Keiji
    Ogata, Hideto
    Kato, Shota
    Ueno, Hiroo
    Umeda, Katsutsugu
    Isobe, Tomoya
    Kubota, Yasuo
    Sekiguchi, Masahiro
    Kimura, Shunsuke
    Sato-Otsubo, Aiko
    Hiwatari, Mitsuteru
    Ushiku, Tetsuo
    Kato, Motohiro
    Oka, Akira
    Miyano, Satoru
    Ogawa, Seishi
    Takita, Junko
    CANCER GENE THERAPY, 2024, 31 (07) : 1049 - 1059
  • [30] C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer
    Lee, Po-Chu
    Chen, Syue-Ting
    Kuo, Ting-Chun
    Lino, Tzu-Chi
    Lin, Mei-Chun
    Huang, John
    Hung, Ji-Shiang
    Hsu, Chia-Lang
    Juan, Hsueh-Fen
    Lee, Po-Huang
    Huang, Min-Chuan
    ONCOGENE, 2020, 39 (13) : 2724 - 2740